News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 830
- Sources here
- 19
- Companies here
- 17
Active search
830 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Nayax Files for Connecticut Innovation Bank Charter and Launches Yellow Account for SMB Customers
Nayax Ltd. has filed an application to establish Nayax America Bank Inc., a non-depository innovation bank in Connecticut, aiming to offer embedded financial services like corporate cards and merchant cash advances to its U.S. customers. Concurrently, Nayax launched its Yellow Account service for SMBs, …
Nayax Launches Yellow Account With Debit Cards for Small Businesses
Nayax (Nasdaq: NYAX) has filed an application with the Connecticut Department of Banking to establish Nayax America Bank, a non-depository innovation bank, to offer embedded financial services like corporate cards and working-capital solutions to U.S. business customers. Concurrently, Nayax launched "Yellow Account" for SMBs, …
Electrovaya to Participate in Upcoming Investor Conferences
Electrovaya Inc. announced that its management team will be participating in four upcoming investor conferences in August and September 2026. These events include Citi's Natural Resources Conference, Needham Virtual Industrial Tech, Robotics, & Power 1x1 Conference, Midwest IDEAS Conference, and Barclays Energy-Power Conference. The …
Nayax (Nasdaq: NYAX) applies to charter Nayax America Bank in Connecticut
Fintech company Nayax (NASDAQ:NYAX) has applied for a bank charter in Connecticut to establish Nayax America Bank as a non-depository innovation bank. The company, which provides payments and merchant services to 120,000 customers globally, aims to offer more embedded financial services like corporate cards …
Himalaya Shipping Ltd. (HSHP) – Invitation to Second Quarter 2026 Conference Call
Himalaya Shipping Ltd. (HSHP) announced an invitation to its Second Quarter 2026 Conference Call, scheduled for Tuesday, August 11, 2026, at 9:00 a.m. Eastern Time (3:00 p.m. CET). The company plans to release its financial results for the second quarter of 2026 before the …
Tenaya Therapeutics Q2 net loss widens on impairment charge
Tenaya Therapeutics (TNYA) reported a widening net loss in the second quarter due to an impairment charge. This financial result was covered by Reuters and is available on TradingView News. Investors can find further details and analysis on the TradingView platform.
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Tenaya Therapeutics has announced its financial results for the second quarter of 2026 and provided an update on its business operations. This report likely details the company's financial performance, key developments in its therapeutic pipeline, and strategic outlook for the coming months.
The Bull Case For IDEAYA Biosciences (IDYA) Could Change Following Wider Loss And New Roche Partnership
IDEAYA Biosciences recently reported a wider Q2 2026 net loss of US$112.45 million, or US$1.22 per share, and an overall wider six-month loss compared to the previous year. Despite this, the company is advancing its precision oncology pipeline, initiating a monotherapy expansion for IDE892 …
IDEAYA Biosciences 2Q 2026: Revenue $8.86M, EPS $(1.22) — 10-Q Summary
IDEAYA Biosciences reported its second-quarter 2026 results, showing collaboration revenue of $8.86 million and a net loss of $(112.45) million, or $(1.22) diluted EPS, due to increased R&D and commercial preparation. The company highlighted positive Phase 2/3 clinical trial results for darovasertib, with an …
Himalaya Shipping (HSHP) Projected to Announce Earnings on Tuesday
Himalaya Shipping (HSHP) is expected to report its Q2 2026 earnings before market open on Tuesday, August 11th. Analysts project earnings of $0.4932 per share and revenue of $50.812 million. The company's previous quarter missed EPS estimates but exceeded revenue expectations, and institutional investors …
Electrovaya publishes update to financial calendar
Electrovaya has updated its financial calendar, announcing that its Q3 2026 financial results will be released on August 10, 2026, after market close. A conference call and webcast to discuss these results and provide a business update are scheduled for August 11, 2026, at …
Electrovaya sets Aug. 11 webcast with CEO and CFO
Electrovaya (Nasdaq: ELVA; TSX: ELVA) announced it will release its Q3 2026 financial results after market close on Monday, August 10, 2026. This will be followed by a conference call and webcast on Tuesday, August 11, 2026, at 8:30 a.m. ET, hosted by CEO …
Electrovaya Announces date for Q3-2026 Financial Results & Conference Call
Electrovaya Inc. (NASDAQ: ELVA; TSX: ELVA) will release its third-quarter financial results for the period ending June 30, 2026, after market close on Monday, August 10, 2026. A conference call and webcast will follow on Tuesday, August 11, 2026, at 8:30 a.m. EST, hosted …
IDEAYA BIOSCIENCES, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $31 FROM $37
Leerink Partners has decreased its target price for IDEAYA Biosciences, Inc. (IDYA.O) from $37 to $31. This adjustment was reported by Reuters on August 5, 2026, at 12:21 PM. The article provides this key financial action without further elaborating on the reasons behind the …
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
Tenaya Therapeutics will participate in the Canaccord Genuity 46th Annual Growth Conference, with members of management hosting 1x1 investor meetings from August 11-12, 2026. Eric Hyllengren, Tenaya's Chief Financial Officer, will also hold a fireside chat on August 11, 2026, which will be webcast …
IDEAYA Biosciences (IDYA) Stock Faces Loss Pressure Despite Revenue Traction
IDEAYA Biosciences (IDYA) stock saw a modest increase after its Q2 2026 earnings report, which highlighted significant revenue growth but also widening net losses. While the company achieved substantial revenue traction and secured new funding, its increasing cash burn and lack of a clear …
IDEAYA Biosciences (NASDAQ: IDYA) reports $1.24B cash and rising R&D spend
IDEAYA Biosciences reported Q2 2026 collaboration revenue of $8.9 million and a net loss of $112.5 million, with R&D expenses significantly increasing to $108.7 million for the quarter. The company strengthened its liquidity through a June 2026 follow-on offering and at-the-market sales, boosting cash, …
Uveal melanoma trial reports 6.9 months progression-free vs. 3.1
IDEAYA Biosciences (IDYA) announced positive results from its registrational Phase 2/3 OptimUM-02 trial for darovasertib plus crizotinib in metastatic uveal melanoma, meeting its primary endpoint with a median progression-free survival (PFS) of 6.9 months compared to 3.1 months for the investigator's choice arm. The …
(BBVA) as a Liquidity Pulse for Institutional Tactics
This article provides an AI-driven analysis of Banco Bilbao Vizcaya Argentaria S.a. (NASDAQ: BBVA), highlighting strong sentiment across all time horizons and compelling upside potential due to the absence of resistance levels above the current price. It outlines specific institutional trading strategies, including long, …
Tenaya CFO Eric Hyllengren to Speak at Boston Conference
Tenaya Therapeutics (NASDAQ: TNYA) announced that its CFO, Eric Hyllengren, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 11, 2026, at 12:30 p.m. ET. The company will also host 1x1 investor meetings during the conference, which …
Insider Selling: Nayax (NASDAQ:NYAX) Insider Sells 276 Shares of Stock
Nayax (NASDAQ:NYAX) insider Aaron Samuel Greenberg sold 276 shares of the company's stock for $19,052.28, primarily to cover tax obligations from vested equity awards. This sale reduced his total holdings by 1.08%. Nayax shares experienced a drop of $2.09 to $67.49, bringing its market …